Cargando…
Utilization of Receptor-Binding Domain of SARS-CoV-2 Spike Protein Expressed in Escherichia coli for the Development of Neutralizing Antibody Assay
The ongoing COVID-19 pandemic has resulted from widespread infection by the SARS-CoV-2 virus. As new variants of concern continue to emerge, understanding the correlation between the level of neutralizing antibodies (NAb) and clinical protection from SAR-CoV-2 infection could be critical in planning...
Autores principales: | Tantiwiwat, Termsak, Thaiprayoon, Apisitt, Siriatcharanon, Ake-kavitch, Tachaapaikoon, Chakrit, Plongthongkum, Nongluk, Waraho-Zhmayev, Dujduan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472194/ https://www.ncbi.nlm.nih.gov/pubmed/36103078 http://dx.doi.org/10.1007/s12033-022-00563-4 |
Ejemplares similares
-
Investigation of interactions between binding residues and solubility of grafted humanized anti-VEGF IgG antibodies expressed as full-length format in the cytoplasm of a novel engineered E. coli SHuffle strain
por: Sangpheak, Kanyani, et al.
Publicado: (2021) -
Twin-arginine translocase component TatB performs folding quality control via a chaperone-like activity
por: Taw, May N., et al.
Publicado: (2022) -
Computational affinity maturation of camelid single-domain intrabodies against the nonamyloid component of alpha-synuclein
por: Mahajan, Sai Pooja, et al.
Publicado: (2018) -
A survival selection strategy for engineering synthetic binding proteins that specifically recognize post-translationally phosphorylated proteins
por: Meksiriporn, Bunyarit, et al.
Publicado: (2019) -
Computational design of novel nanobodies targeting the receptor binding domain of variants of concern of SARS-CoV-2
por: Longsompurana, Phoomintara, et al.
Publicado: (2023)